Literature DB >> 11897429

Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers.

Mayumi Torii1, Yoshiharu Takiguchi, Miyako Izumi, Tokuya Fukushima, Masayuki Yokota.   

Abstract

The concomitant use of carbapenem antibiotics with valproic acid has been prohibited because carbapenems induced a decrease in plasma concentration of valproic acid in epileptic patients during valproic acid therapy. Our previous in vivo study in rats proposed that inhibition by carbapenem of the intestinal absorption of valproic acid might be a possible mechanism for the drug-drug interaction. To demonstrate the hypothesis, we examined the effects of imipenem and panipenem on intestinal transepithelial transport of valproic acid using Caco-2 cell monolayers. Imipenem and panipenem inhibited the transport of [14C]-valproic acid across the Caco-2 cell monolayers from apical-to-basolateral side in a concentration-dependent manner, although they had no effect on the uptake of [14C]-valproic acid by Caco-2 cells. The inhibition by the carbapenems of the valproic acid transport was found even when they were added to only the basolateral side. From these results, the carbapenems may inhibit the absorption of valproic acid at the basolateral membrane of intestinal epithelial cells, which contributes to the decrease in plasma concentration of valproic acid after oral administration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897429     DOI: 10.1016/s0378-5173(01)00916-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Ertapenem-induced reduction in valproate levels: case report and review of the literature.

Authors:  Duane Bates; Michael Parkins; Keltie Duggan
Journal:  Can J Hosp Pharm       Date:  2010-07

Review 2.  Panipenem/betamipron.

Authors:  Karen L Goa; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Valproate Interaction With Carbapenems: Review and Recommendations.

Authors:  Osama Al-Quteimat; Alla Laila
Journal:  Hosp Pharm       Date:  2019-02-22

4.  Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.

Authors:  Koichi Fujimoto; Koji Takemoto; Kazuo Hatano; Toru Nakai; Shigeyuki Terashita; Masahiro Matsumoto; Yoshiro Eriguchi; Ken Eguchi; Takeshi Shimizudani; Kimihiko Sato; Katsunori Kanazawa; Makoto Sunagawa; Yutaka Ueda
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

5.  Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient.

Authors:  Hiroaki Ikeda; Teruo Murakami; Mikihisa Takano; Tsuguru Usui; Kenji Kihira
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

6.  Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.

Authors:  Todd M Conner; Vahagn C Nikolian; Patrick E Georgoff; Manjunath P Pai; Hasan B Alam; Duxin Sun; Ronald C Reed; Tao Zhang
Journal:  Eur J Pharm Sci       Date:  2017-10-10       Impact factor: 4.384

7.  Carbapenems and valproate: A consumptive relationship.

Authors:  Peter Bede; Diane Lawlor; Damodar Solanki; Norman Delanty
Journal:  Epilepsia Open       Date:  2016-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.